National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2019-27185"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2019-27185"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2019-12-18"
last_updated: "2019-12-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-27185"
document_type: "notice"
publication_date: "2019-12-18"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "84 FR 69384"
fr_volume: 84
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Initial Review Group TEP-3: SBIR Contract Review, February 6, 2020, 10:00 a.m. to 6:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 5E030, Rockville, MD 20850 (Telephone Conference Call) which was published in the *Federal Register* on December 10, 2019, 84 FR 67467.

This meeting notice is amended to correct the meeting name from National Cancer Institute Initial Review Group TEP-3: SBIR Contract Review to National Cancer Institute Special Emphasis Panel TEP-3: SBIR Contract Review. The meeting is closed to the public.

Dated: December 12, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.